首页 > 最新文献

In vivo最新文献

英文 中文
Contribution of Radiation Sensitive Protein 51 Genotypes to Pterygium Risk in a Taiwanese Population. 台湾人群中辐射敏感蛋白 51 基因型对翼状胬肉风险的影响
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13683
Ning-Yi Hsia, Pei-Shin Hu, Chin-Liang Chuang, Mei-Chin Mong, Hung-Chih Chen, Chia-Wen Tsai, Yun-Chi Wang, Jaw-Chyun Chen, DA-Tian Bau, Wen-Shin Chang

Background/aim: In current literature, there is a notable lack of studies investigating the role of radiation-sensitive protein 51 (RAD-51) in pterygium diagnosis. Nevertheless, reports indicate elevated expression levels of RAD-51 among recurrent pterygium cases compared to those with primary pterygium. However, the genomic involvement of RAD-51 has yet to be explored in any population. This study aimed to assess the contribution of RAD-51 genotypes to pterygium risk in a representative Taiwanese population.

Materials and methods: RAD-51 rs1801320 genotyping was successfully conducted in a Taiwanese cohort comprising 140 pterygium cases and 280 non-pterygium controls using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technology.

Results: The distribution of RAD-51 rs1801320 genotypes (GG, CG, and CC) in the pterygium group (70.0%, 25.7%, and 4.3%, respectively) did not significantly differ from that in the non-pterygium group (73.6%, 23.6%, and 2.8% for GG, CG, and CC genotypes, respectively; p for trend=0.6337). Carriers of the variant CG and CC RAD-51 rs1801320 genotypes exhibited 1.15- and 1.58-fold increased pterygium risk, respectively (95%CI=0.72-1.84 and 0.53-4.67, p=0.6552 and p=0.5914, respectively). In the dominant model, there appeared to be a slight association between variant genotypes CG and CC and pterygium risk (OR=1.19, 95%CI=0.76-1.87, p=0.0223). Allelic analysis revealed that the RAD-51 rs1801320 variant C allele was not significantly linked to pterygium risk (17.1% versus 14.6%, OR=1.20, 95%CI=0.82-1.78, p=0.3991).

Conclusion: Variant genotypes at RAD-51 rs1801320 were firstly identified to associate with susceptibility to pterygium among Taiwanese individuals. Nonetheless, these findings warrant validation in larger and more diverse populations.

背景/目的:在目前的文献中,明显缺乏对辐射敏感蛋白 51(RAD-51)在翼状胬肉诊断中作用的研究。然而,有报告显示,与原发性翼状胬肉相比,复发性翼状胬肉病例中 RAD-51 的表达水平较高。然而,RAD-51 的基因组参与尚未在任何人群中进行探讨。本研究旨在评估具有代表性的台湾人群中 RAD-51 基因型对翼状胬肉风险的贡献:采用聚合酶链式反应-限制性片段长度多态性(PCR-RFLP)技术,在由140例翼状胬肉病例和280例非翼状胬肉对照组成的台湾队列中成功进行了RAD-51 rs1801320基因分型:结果:RAD-51 rs1801320基因型(GG、CG和CC)在翼状胬肉组中的分布(分别为70.0%、25.7%和4.3%)与非翼状胬肉组中的分布(GG、CG和CC基因型分别为73.6%、23.6%和2.8%;趋势p=0.6337)无显著差异。变异 CG 和 CC RAD-51 rs1801320 基因型携带者的翼状胬肉风险分别增加了 1.15 倍和 1.58 倍(95%CI=0.72-1.84 和 0.53-4.67,p=0.6552 和 p=0.5914)。在显性模型中,变异基因型 CG 和 CC 与翼状胬肉风险之间似乎有轻微的关联(OR=1.19,95%CI=0.76-1.87,p=0.0223)。等位基因分析表明,RAD-51 rs1801320变异的C等位基因与翼状胬肉风险无显著联系(17.1%对14.6%,OR=1.20,95%CI=0.82-1.78,p=0.3991):RAD-51 rs1801320的变异基因型首次被发现与台湾人的翼状胬肉易感性有关。结论:RAD-51 rs1801320的变异基因型首次在台湾人中被发现与翼状胬肉的易感性有关。
{"title":"Contribution of Radiation Sensitive Protein 51 Genotypes to Pterygium Risk in a Taiwanese Population.","authors":"Ning-Yi Hsia, Pei-Shin Hu, Chin-Liang Chuang, Mei-Chin Mong, Hung-Chih Chen, Chia-Wen Tsai, Yun-Chi Wang, Jaw-Chyun Chen, DA-Tian Bau, Wen-Shin Chang","doi":"10.21873/invivo.13683","DOIUrl":"10.21873/invivo.13683","url":null,"abstract":"<p><strong>Background/aim: </strong>In current literature, there is a notable lack of studies investigating the role of radiation-sensitive protein 51 (RAD-51) in pterygium diagnosis. Nevertheless, reports indicate elevated expression levels of RAD-51 among recurrent pterygium cases compared to those with primary pterygium. However, the genomic involvement of RAD-51 has yet to be explored in any population. This study aimed to assess the contribution of RAD-51 genotypes to pterygium risk in a representative Taiwanese population.</p><p><strong>Materials and methods: </strong>RAD-51 rs1801320 genotyping was successfully conducted in a Taiwanese cohort comprising 140 pterygium cases and 280 non-pterygium controls using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technology.</p><p><strong>Results: </strong>The distribution of RAD-51 rs1801320 genotypes (GG, CG, and CC) in the pterygium group (70.0%, 25.7%, and 4.3%, respectively) did not significantly differ from that in the non-pterygium group (73.6%, 23.6%, and 2.8% for GG, CG, and CC genotypes, respectively; p for trend=0.6337). Carriers of the variant CG and CC RAD-51 rs1801320 genotypes exhibited 1.15- and 1.58-fold increased pterygium risk, respectively (95%CI=0.72-1.84 and 0.53-4.67, p=0.6552 and p=0.5914, respectively). In the dominant model, there appeared to be a slight association between variant genotypes CG and CC and pterygium risk (OR=1.19, 95%CI=0.76-1.87, p=0.0223). Allelic analysis revealed that the RAD-51 rs1801320 variant C allele was not significantly linked to pterygium risk (17.1% versus 14.6%, OR=1.20, 95%CI=0.82-1.78, p=0.3991).</p><p><strong>Conclusion: </strong>Variant genotypes at RAD-51 rs1801320 were firstly identified to associate with susceptibility to pterygium among Taiwanese individuals. Nonetheless, these findings warrant validation in larger and more diverse populations.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363769/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytomegalovirus Ileitis in a Patient With Post-severe Trauma: A Case Report. 严重创伤后患者的巨细胞病毒性回肠炎:病例报告。
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13731
Yi-Yen Tsai, Jeng-Wei Lu, Chih-Chien Wang

Background/aim: The mortality rate for alimentary tract hemorrhage remains high due to a variety of contributing factors. In this report, we present a case of post-severe trauma patient with life-threatening gastrointestinal bleeding caused by cytomegalovirus (CMV)-induced damage to the terminal ileum.

Case report: A 76-year-old female with a history of hypertension and gastrointestinal bleeding developed CMV ileitis post-severe trauma. Despite negative CMV IgM antibodies, PCR testing confirmed CMV infection in the biopsy tissue. Histopathological examination revealed viral inclusion bodies, with immunohistochemistry confirming CMV presence.

Results: Intravenous ganciclovir effectively managed symptoms and halted bleeding. CMV ileitis, typically seen in immunocompromised states, may occur sporadically in immunocompetent individuals, including post-orthopedic surgery patients. The exact mechanism remains unclear, possibly related to surgical stress. Diagnosis relies on histopathology and immunohistochemistry.

Conclusion: Early recognition and treatment are vital for optimal outcomes, emphasizing the need for awareness among orthopedic surgeons regarding CMV as a potential cause of postoperative complications.

背景/目的:由于多种诱因,消化道出血的死亡率一直居高不下。在本报告中,我们介绍了一例严重创伤后患者因巨细胞病毒(CMV)引起的回肠末端损伤而导致的危及生命的消化道出血:一名有高血压和消化道出血病史的 76 岁女性在严重创伤后患上了 CMV 回肠炎。尽管 CMV IgM 抗体呈阴性,但 PCR 检测证实活检组织中存在 CMV 感染。组织病理学检查发现了病毒包涵体,免疫组化证实了 CMV 的存在:结果:静脉注射更昔洛韦有效控制了症状并止住了出血。CMV 回肠炎通常见于免疫功能低下的状态,但也可能偶发于免疫功能正常的个体,包括矫形手术后的患者。确切的发病机制尚不清楚,可能与手术应激有关。诊断依赖于组织病理学和免疫组化:结论:早期识别和治疗对获得最佳疗效至关重要,强调骨科医生需要认识到 CMV 是导致术后并发症的潜在原因。
{"title":"Cytomegalovirus Ileitis in a Patient With Post-severe Trauma: A Case Report.","authors":"Yi-Yen Tsai, Jeng-Wei Lu, Chih-Chien Wang","doi":"10.21873/invivo.13731","DOIUrl":"10.21873/invivo.13731","url":null,"abstract":"<p><strong>Background/aim: </strong>The mortality rate for alimentary tract hemorrhage remains high due to a variety of contributing factors. In this report, we present a case of post-severe trauma patient with life-threatening gastrointestinal bleeding caused by cytomegalovirus (CMV)-induced damage to the terminal ileum.</p><p><strong>Case report: </strong>A 76-year-old female with a history of hypertension and gastrointestinal bleeding developed CMV ileitis post-severe trauma. Despite negative CMV IgM antibodies, PCR testing confirmed CMV infection in the biopsy tissue. Histopathological examination revealed viral inclusion bodies, with immunohistochemistry confirming CMV presence.</p><p><strong>Results: </strong>Intravenous ganciclovir effectively managed symptoms and halted bleeding. CMV ileitis, typically seen in immunocompromised states, may occur sporadically in immunocompetent individuals, including post-orthopedic surgery patients. The exact mechanism remains unclear, possibly related to surgical stress. Diagnosis relies on histopathology and immunohistochemistry.</p><p><strong>Conclusion: </strong>Early recognition and treatment are vital for optimal outcomes, emphasizing the need for awareness among orthopedic surgeons regarding CMV as a potential cause of postoperative complications.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363795/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Tissue-derived Angiotensinogen on Kidney Injury and Fibrosis in Obstructive Nephropathy. 组织源性血管紧张素原对阻塞性肾病肾损伤和纤维化的影响
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13672
Hee-Seong Jang, Mi Ra Noh, Ligyeom Ha, Jinu Kim, Babu J Padanilam

Background/aim: Angiotensinogen (AGT), a precursor of angiotensin II (AngII), contributes to regulating (patho)physiological conditions, including blood pressure changes, inflammation, and kidney fibrosis. However, the precise role of tissue-specific AGT in kidney fibrosis independent of blood pressure remains to be fully understood. This study investigated the source of intrarenal AGT and its role in kidney injury and fibrosis during obstructive nephropathy.

Materials and methods: Proximal tubule- (PT, major source secreting AGT in the kidney; PKO) or liver- (major source of circulating AGT; LKO) AGT knockout (KO) mice were subjected to unilateral ureteral obstruction (UUO), a blood pressure-independent fibrosis model.

Results: UUO increased AGT mRNA and protein levels in the kidneys. PKO decreased AGT mRNA, but LKO enhanced it in UUO kidneys compared with the control. In contrast, the intrarenal protein levels of AGT increased in PKO, but not in LKO in UUO kidneys, indicating that the liver is a major source of intrarenal AGT protein. Expression of megalin, a PT receptor involved in the uptake of circulating AGT, was down-regulated in UUO kidneys and was independent of PKO or LKO. However, none of these changes prevented UUO-induced tubular injury and kidney fibrosis.

Conclusion: Hepatic and proximal tubule AGT play distinct roles in contributing to intrarenal AGT levels during UUO, and their genetic inhibitions fail to prevent kidney injury and fibrosis, suggesting a highly complicated signaling pathway of the renin-angiotensin system and an associated compensatory mechanism in obstructive nephropathy.

背景/目的:血管紧张素原(AGT)是血管紧张素 II(AngII)的前体,有助于调节(病理)生理状况,包括血压变化、炎症和肾脏纤维化。然而,与血压无关的组织特异性 AGT 在肾脏纤维化中的确切作用仍有待充分了解。本研究调查了肾内 AGT 的来源及其在阻塞性肾病期间肾脏损伤和纤维化中的作用:对AGT基因敲除(KO)小鼠进行单侧输尿管梗阻(UUO),这是一种血压依赖性纤维化模型:结果:UUO增加了肾脏中AGT mRNA和蛋白水平。与对照组相比,PKO 降低了 UUO 肾脏中 AGT mRNA 的水平,但 LKO 提高了 AGT mRNA 的水平。与此相反,PKO 会增加肾内 AGT 蛋白水平,而 LKO 不会增加 UUO 肾内 AGT 蛋白水平,这表明肝脏是肾内 AGT 蛋白的主要来源。UUO肾脏中参与吸收循环AGT的PT受体megalin的表达下调,且与PKO或LKO无关。然而,这些变化都不能阻止UUO诱导的肾小管损伤和肾脏纤维化:结论:肝脏和近端肾小管AGT在UUO期间对肾内AGT水平起着不同的作用,对它们的遗传抑制不能防止肾损伤和肾脏纤维化,这表明肾素-血管紧张素系统的信号通路和相关的代偿机制在阻塞性肾病中非常复杂。
{"title":"Effect of Tissue-derived Angiotensinogen on Kidney Injury and Fibrosis in Obstructive Nephropathy.","authors":"Hee-Seong Jang, Mi Ra Noh, Ligyeom Ha, Jinu Kim, Babu J Padanilam","doi":"10.21873/invivo.13672","DOIUrl":"10.21873/invivo.13672","url":null,"abstract":"<p><strong>Background/aim: </strong>Angiotensinogen (AGT), a precursor of angiotensin II (AngII), contributes to regulating (patho)physiological conditions, including blood pressure changes, inflammation, and kidney fibrosis. However, the precise role of tissue-specific AGT in kidney fibrosis independent of blood pressure remains to be fully understood. This study investigated the source of intrarenal AGT and its role in kidney injury and fibrosis during obstructive nephropathy.</p><p><strong>Materials and methods: </strong>Proximal tubule- (PT, major source secreting AGT in the kidney; PKO) or liver- (major source of circulating AGT; LKO) AGT knockout (KO) mice were subjected to unilateral ureteral obstruction (UUO), a blood pressure-independent fibrosis model.</p><p><strong>Results: </strong>UUO increased AGT mRNA and protein levels in the kidneys. PKO decreased AGT mRNA, but LKO enhanced it in UUO kidneys compared with the control. In contrast, the intrarenal protein levels of AGT increased in PKO, but not in LKO in UUO kidneys, indicating that the liver is a major source of intrarenal AGT protein. Expression of megalin, a PT receptor involved in the uptake of circulating AGT, was down-regulated in UUO kidneys and was independent of PKO or LKO. However, none of these changes prevented UUO-induced tubular injury and kidney fibrosis.</p><p><strong>Conclusion: </strong>Hepatic and proximal tubule AGT play distinct roles in contributing to intrarenal AGT levels during UUO, and their genetic inhibitions fail to prevent kidney injury and fibrosis, suggesting a highly complicated signaling pathway of the renin-angiotensin system and an associated compensatory mechanism in obstructive nephropathy.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363765/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the Relationship Between Portal Vein Diameter and Colorectal Liver Metastases on Computed Tomography. 评估计算机断层扫描中门静脉直径与结直肠肝转移之间的关系
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13717
Emrah Karatay, Sahin Lacin, Abdulkadir Eren

Background/aim: The most common and often first metastatic site of colorectal cancer (CRC) is the liver, and radiological modalities have a critical role in the diagnosis of colorectal liver metastasis (CRLM). In this study, the possible relationship between portal vein diameter, number of metastases, and metastasis diameter was evaluated in CRLM patients who underwent computed tomography (CT) examination with intravenous contrast (IV).

Patients and methods: Cases diagnosed with CRLM who underwent abdominal CT examination with IV contrast between December 2020 and January 2024 were retrospectively scanned. People over the age of 18 were included, and cases were divided into three subgroups according to the number of metastases: a (single), b (two), and c (three and/or more).

Results: There were 101 male and 74 female cases; the youngest case was 39 (male) and the oldest case was 87 (male) years old. According to the number of CRLMs, group a had 47 cases, group b had 23, and group c had 105 cases. The minimum diameter of metastasis was 0.74 cm, the maximum was 11.86 cm, and the mean diameter was 4.45±2.67 cm. There was a significant correlation between the presence of metastasis in the left lobe and the diameter of the metastases (p<0.05).

Conclusion: The relationship between portal vein diameter and CRLM using contrast-enhanced CT scans was explored. While no significant correlation was found between portal vein diameters and metastasis size, a notable association was observed between metastasis size and their presence in the left liver lobe. These findings suggest that CRLMs in the left lobe may respond better to preoperative chemotherapy and surgical interventions. This novel insight could help develop targeted treatment strategies for CRLM, though further research with larger cohorts is needed.

背景/目的:肝脏是结直肠癌(CRC)最常见也是最先转移的部位,放射学方法在结直肠癌肝转移(CRLM)的诊断中起着至关重要的作用。本研究评估了接受静脉注射造影剂(IV)的计算机断层扫描(CT)检查的 CRLM 患者的门静脉直径、转移灶数量和转移灶直径之间可能存在的关系:回顾性扫描 2020 年 12 月至 2024 年 1 月期间接受静脉注射造影剂腹部 CT 检查的 CRLM 患者。根据转移灶的数量将病例分为三个亚组:a(单个)、b(两个)和c(三个和/或多个):男性 101 例,女性 74 例;年龄最小的 39 岁(男性),最大的 87 岁(男性)。根据 CRLM 的数量,a 组有 47 例,b 组有 23 例,c 组有 105 例。转移瘤直径最小为 0.74 厘米,最大为 11.86 厘米,平均直径为(4.45±2.67)厘米。左叶有无转移灶与转移灶直径之间有明显的相关性(p结论:通过对比增强 CT 扫描探讨了门静脉直径与 CRLM 之间的关系。虽然门静脉直径与转移灶大小之间没有发现明显的相关性,但却观察到转移灶大小与转移灶是否位于左肝叶之间存在明显的关联。这些发现表明,左叶的 CRLM 对术前化疗和手术干预的反应可能更好。这一新颖见解有助于为CRLM制定有针对性的治疗策略,但还需要对更大的群体进行进一步研究。
{"title":"Evaluation of the Relationship Between Portal Vein Diameter and Colorectal Liver Metastases on Computed Tomography.","authors":"Emrah Karatay, Sahin Lacin, Abdulkadir Eren","doi":"10.21873/invivo.13717","DOIUrl":"10.21873/invivo.13717","url":null,"abstract":"<p><strong>Background/aim: </strong>The most common and often first metastatic site of colorectal cancer (CRC) is the liver, and radiological modalities have a critical role in the diagnosis of colorectal liver metastasis (CRLM). In this study, the possible relationship between portal vein diameter, number of metastases, and metastasis diameter was evaluated in CRLM patients who underwent computed tomography (CT) examination with intravenous contrast (IV).</p><p><strong>Patients and methods: </strong>Cases diagnosed with CRLM who underwent abdominal CT examination with IV contrast between December 2020 and January 2024 were retrospectively scanned. People over the age of 18 were included, and cases were divided into three subgroups according to the number of metastases: a (single), b (two), and c (three and/or more).</p><p><strong>Results: </strong>There were 101 male and 74 female cases; the youngest case was 39 (male) and the oldest case was 87 (male) years old. According to the number of CRLMs, group a had 47 cases, group b had 23, and group c had 105 cases. The minimum diameter of metastasis was 0.74 cm, the maximum was 11.86 cm, and the mean diameter was 4.45±2.67 cm. There was a significant correlation between the presence of metastasis in the left lobe and the diameter of the metastases (p<0.05).</p><p><strong>Conclusion: </strong>The relationship between portal vein diameter and CRLM using contrast-enhanced CT scans was explored. While no significant correlation was found between portal vein diameters and metastasis size, a notable association was observed between metastasis size and their presence in the left liver lobe. These findings suggest that CRLMs in the left lobe may respond better to preoperative chemotherapy and surgical interventions. This novel insight could help develop targeted treatment strategies for CRLM, though further research with larger cohorts is needed.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363781/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Correlation Between Vitamin D Levels and Serological Markers in Liver Diseases: Insights from a Cross-Sectional Study. 探索维生素 D 水平与肝病血清学标志物之间的相关性:一项横断面研究的启示。
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13692
Adina Ioana Mihele, Sergiu Cristian Hocopan, Sergiu Dorin Matei, Roxana Daniela Brata, Daniela Florina Trifan, Liviu Lazăr, Timea Claudia Ghitea

Background/aim: This study investigated the correlation between vitamin D levels and serological markers of liver diseases in two groups of patients: the control group (CG) and the study group (SG).

Materials and methods: The study analyzed data on vitamin D levels categorized as insufficient, sufficient, and optimal, along with serological markers, such as alpha2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin total, gamma-glutamyl transferase (GGT), alanine aminotransferase (ALT), aspartate aminotransferase (AST), glucose, total cholesterol, and triglycerides.

Results: The results indicate significant differences in vitamin D levels between the two groups, particularly in SG, where vitamin D levels varied according to its status and correlated with serological markers. Marker levels, including alpha2-macroglobulin, glucose, and total cholesterol, were notably higher in SG compared to CG, suggesting a potential association with non-alcoholic fatty liver disease (NAFLD). Further analysis using Pearson correlation revealed a strong, inverse relationship between vitamin D levels and FibroTest, NashTest, alpha2-globulin, and glucose. Additionally, increasing FibroTest and NashTest stages, as well as levels of alpha2-macroglobulin and glucose, were associated with lower vitamin D levels in SG.

Conclusion: These findings under-score the complex interplay between vitamin D and serological markers in NAFLD, highlighting the potential significance of vitamin D levels in disease progression. Further research is warranted to elucidate the mechanisms underlying this relationship and its clinical implications.

背景/目的:本研究调查了两组患者(对照组(CG)和研究组(SG))的维生素 D 水平与肝病血清学指标之间的相关性:研究分析了维生素 D 水平(分为不足、充足和最佳)以及甲型 2 巨球蛋白、血红蛋白、脂蛋白 A1、总胆红素、γ-谷氨酰转移酶(GGT)、丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、葡萄糖、总胆固醇和甘油三酯等血清学指标的数据:结果表明,两组之间的维生素 D 水平存在明显差异,特别是在 SG 中,维生素 D 水平因其状态而异,并与血清学指标相关。与 CG 相比,SG 中的α2-巨球蛋白、葡萄糖和总胆固醇等指标水平明显更高,这表明可能与非酒精性脂肪肝(NAFLD)有关。利用皮尔逊相关性进行的进一步分析表明,维生素 D 水平与纤维试验、纳什试验、α2-球蛋白和葡萄糖之间存在密切的反向关系。此外,纤维试验和纳什试验阶段以及α2-巨球蛋白和葡萄糖水平的增加与 SG 中维生素 D 水平的降低有关:这些发现揭示了非酒精性脂肪肝中维生素 D 与血清学标志物之间复杂的相互作用,强调了维生素 D 水平在疾病进展中的潜在意义。我们有必要开展进一步研究,以阐明这种关系的内在机制及其临床意义。
{"title":"Exploring the Correlation Between Vitamin D Levels and Serological Markers in Liver Diseases: Insights from a Cross-Sectional Study.","authors":"Adina Ioana Mihele, Sergiu Cristian Hocopan, Sergiu Dorin Matei, Roxana Daniela Brata, Daniela Florina Trifan, Liviu Lazăr, Timea Claudia Ghitea","doi":"10.21873/invivo.13692","DOIUrl":"10.21873/invivo.13692","url":null,"abstract":"<p><strong>Background/aim: </strong>This study investigated the correlation between vitamin D levels and serological markers of liver diseases in two groups of patients: the control group (CG) and the study group (SG).</p><p><strong>Materials and methods: </strong>The study analyzed data on vitamin D levels categorized as insufficient, sufficient, and optimal, along with serological markers, such as alpha2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin total, gamma-glutamyl transferase (GGT), alanine aminotransferase (ALT), aspartate aminotransferase (AST), glucose, total cholesterol, and triglycerides.</p><p><strong>Results: </strong>The results indicate significant differences in vitamin D levels between the two groups, particularly in SG, where vitamin D levels varied according to its status and correlated with serological markers. Marker levels, including alpha2-macroglobulin, glucose, and total cholesterol, were notably higher in SG compared to CG, suggesting a potential association with non-alcoholic fatty liver disease (NAFLD). Further analysis using Pearson correlation revealed a strong, inverse relationship between vitamin D levels and FibroTest, NashTest, alpha2-globulin, and glucose. Additionally, increasing FibroTest and NashTest stages, as well as levels of alpha2-macroglobulin and glucose, were associated with lower vitamin D levels in SG.</p><p><strong>Conclusion: </strong>These findings under-score the complex interplay between vitamin D and serological markers in NAFLD, highlighting the potential significance of vitamin D levels in disease progression. Further research is warranted to elucidate the mechanisms underlying this relationship and its clinical implications.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363789/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toward Inclusive Oncology: Challenges in the Therapy of Pediatric Non-B Non-Hodgkin Lymphomas. 迈向包容性肿瘤学:小儿非 B 型非霍奇金淋巴瘤治疗面临的挑战》。
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13708
Joanna Stankiewicz, Anna Jabłońska, Paweł Treichel, Jan Styczyński

Background/aim: Non-B non-Hodgkin lymphomas (NHL) represent over 30 T/NK lymphoma types. The majority of them are T-cell lymphoblastic lymphomas (TLL) and anaplastic large cell lymphomas (ALCL). Other rare non-B NHLs represent a diverse group of neoplasms, usually excluded from clinical trials. This study analyzed outcomes in pediatric patients with non-B NHL in a single oncology center with particular emphasis on patients with rare NHLs.

Patients and methods: We retrospectively analyzed data from patients <18 years with newly diagnosed non-B NHL treated at the Department of Pediatric Hematology and Oncology in Bydgoszcz between 2002 and 2022. The probability of 5-year overall survival (pOS) and event-free survival (pEFS) were calculated for the entire cohort and patients with TLL and ALCL. The clinical course for patients with rare non-B NHL was described in detail.

Results: Twenty-six children were eligible for analysis. Fourteen patients were diagnosed with ALCL, nine with TLL, and three with rare NHL types (subcutaneous panniculitis-like T-cell lymphoma, extranodal NK/T-cell lymphoma and hydroa vacciniforme-like lymphoproliferative disease associated lymphoma). For the entire group, the 5-year pOS was 83.7% and the 5-year pEFS was 72.4%. For TLL and ALCL, the outcomes were comparable with those achieved in clinical trials. Patients with rare NHL were treated according to individualized therapy recommendations based on physicians' expertise and available case report descriptions.

Conclusion: There is a lack of knowledge on optimal therapeutic strategies for rare NHLs. It is crucial to create trials dedicated to uncommon NHLs and establish therapy guidelines for these patients.

背景/目的:非B型非霍奇金淋巴瘤(NHL)代表了30多种T/NK淋巴瘤类型。其中大多数是T细胞淋巴细胞淋巴瘤(TLL)和无细胞大细胞淋巴瘤(ALCL)。其他罕见的非 B 型 NHL 代表了一个多样化的肿瘤群体,通常被排除在临床试验之外。本研究分析了一家肿瘤中心的非B型NHL儿科患者的治疗效果,重点关注罕见NHL患者:我们对患者的数据进行了回顾性分析:26名儿童符合分析条件。14名患者被确诊为ALCL,9名患者被确诊为TLL,3名患者被确诊为罕见NHL类型(皮下泛发性类T细胞淋巴瘤、结节外NK/T细胞淋巴瘤和水瘤疫苗样淋巴增生性疾病相关淋巴瘤)。整组患者的5年pOS为83.7%,5年pEFS为72.4%。TLL和ALCL的疗效与临床试验结果相当。根据医生的专业知识和现有病例报告的描述,罕见NHL患者按照个体化治疗建议进行治疗:结论:目前对罕见NHL的最佳治疗策略还缺乏了解。结论:人们对罕见NHL的最佳治疗策略缺乏了解,因此必须开展针对罕见NHL的试验,并为这些患者制定治疗指南。
{"title":"Toward Inclusive Oncology: Challenges in the Therapy of Pediatric Non-B Non-Hodgkin Lymphomas.","authors":"Joanna Stankiewicz, Anna Jabłońska, Paweł Treichel, Jan Styczyński","doi":"10.21873/invivo.13708","DOIUrl":"10.21873/invivo.13708","url":null,"abstract":"<p><strong>Background/aim: </strong>Non-B non-Hodgkin lymphomas (NHL) represent over 30 T/NK lymphoma types. The majority of them are T-cell lymphoblastic lymphomas (TLL) and anaplastic large cell lymphomas (ALCL). Other rare non-B NHLs represent a diverse group of neoplasms, usually excluded from clinical trials. This study analyzed outcomes in pediatric patients with non-B NHL in a single oncology center with particular emphasis on patients with rare NHLs.</p><p><strong>Patients and methods: </strong>We retrospectively analyzed data from patients <18 years with newly diagnosed non-B NHL treated at the Department of Pediatric Hematology and Oncology in Bydgoszcz between 2002 and 2022. The probability of 5-year overall survival (pOS) and event-free survival (pEFS) were calculated for the entire cohort and patients with TLL and ALCL. The clinical course for patients with rare non-B NHL was described in detail.</p><p><strong>Results: </strong>Twenty-six children were eligible for analysis. Fourteen patients were diagnosed with ALCL, nine with TLL, and three with rare NHL types (subcutaneous panniculitis-like T-cell lymphoma, extranodal NK/T-cell lymphoma and hydroa vacciniforme-like lymphoproliferative disease associated lymphoma). For the entire group, the 5-year pOS was 83.7% and the 5-year pEFS was 72.4%. For TLL and ALCL, the outcomes were comparable with those achieved in clinical trials. Patients with rare NHL were treated according to individualized therapy recommendations based on physicians' expertise and available case report descriptions.</p><p><strong>Conclusion: </strong>There is a lack of knowledge on optimal therapeutic strategies for rare NHLs. It is crucial to create trials dedicated to uncommon NHLs and establish therapy guidelines for these patients.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363777/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utility for Postoperative Respiratory Function of Transmediastinal Esophagectomy for Esophageal Carcinoma. 食管癌经纵隔食管切除术术后呼吸功能的实用性。
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13702
Shutaro Sumiyoshi, Atsushi Shiozaki, Hitoshi Fujiwara, Hirotaka Konishi, Hiroyuki Inoue, Kazuya Takabatake, Keiji Nishibeppu, Jun Kiuchi, Taisuke Imamura, Kenji Nanishi, Hiroki Shimizu, Tomohiro Arita, Yusuke Yamamoto, Ryo Morimura, Takeshi Kubota, Eigo Otsuji

Background/aim: Esophagectomy for esophageal carcinoma (EC) is known to lead to deterioration of respiratory function (RF) due to thoracotomy and mediastinal lymph node dissection. This study aimed to evaluate the impact of transmediastinal esophagectomy (TME) on pulmonary function.

Patients and methods: We retrospectively analyzed the data of 102 patients with EC who underwent transthoracic esophagectomy (TTE) or TME and underwent RF tests within three months postoperatively at Kyoto Prefectural University of Medicine between 2014 and 2022. Perioperative pulmonary functions were evaluated based on vital capacity (VC) and forced expiratory volume in one second (FEV1.0).

Results: Among 102 patients undergoing esophagectomy, 12 (11.8%) patients were included in the TTE group, and the remaining 90 (88.2%) patients were included in the TME group. Neoadjuvant treatments were significantly more common in the TTE group (p=0.011), with more advanced tumor stages (p=0.017). The TME group had significantly lower estimated blood loss (p=0.015). RF after esophagectomy showed a decrease in VC, and VC of predicted (%VC). The decrease rate in VC, %VC, and FEV1.0 was significantly greater in the TTE group than in the TME group.

Conclusion: TME is a surgical procedure with a less severe postoperative decline in RF than TTE.

背景/目的:众所周知,食管癌(EC)食管切除术会因开胸、纵隔淋巴结清扫而导致呼吸功能(RF)恶化。本研究旨在评估经纵隔食管切除术(TME)对肺功能的影响:我们回顾性分析了2014年至2022年间在京都府立医科大学接受经胸食管切除术(TTE)或TME并在术后三个月内接受射频检查的102例EC患者的数据。围手术期肺功能评估基于生命容量(VC)和一秒用力呼气容积(FEV1.0):在102名接受食管切除术的患者中,12名(11.8%)患者被纳入TTE组,其余90名(88.2%)患者被纳入TME组。TTE 组患者接受新辅助治疗的比例明显更高(P=0.011),肿瘤分期也更晚(P=0.017)。TME组的估计失血量明显更少(p=0.015)。食管切除术后的射频显示出 VC 和预测 VC(%VC)的下降。TTE组VC、%VC和FEV1.0的下降率明显高于TME组:结论:与 TTE 相比,TME 是一种术后射频下降较轻的外科手术。
{"title":"Utility for Postoperative Respiratory Function of Transmediastinal Esophagectomy for Esophageal Carcinoma.","authors":"Shutaro Sumiyoshi, Atsushi Shiozaki, Hitoshi Fujiwara, Hirotaka Konishi, Hiroyuki Inoue, Kazuya Takabatake, Keiji Nishibeppu, Jun Kiuchi, Taisuke Imamura, Kenji Nanishi, Hiroki Shimizu, Tomohiro Arita, Yusuke Yamamoto, Ryo Morimura, Takeshi Kubota, Eigo Otsuji","doi":"10.21873/invivo.13702","DOIUrl":"10.21873/invivo.13702","url":null,"abstract":"<p><strong>Background/aim: </strong>Esophagectomy for esophageal carcinoma (EC) is known to lead to deterioration of respiratory function (RF) due to thoracotomy and mediastinal lymph node dissection. This study aimed to evaluate the impact of transmediastinal esophagectomy (TME) on pulmonary function.</p><p><strong>Patients and methods: </strong>We retrospectively analyzed the data of 102 patients with EC who underwent transthoracic esophagectomy (TTE) or TME and underwent RF tests within three months postoperatively at Kyoto Prefectural University of Medicine between 2014 and 2022. Perioperative pulmonary functions were evaluated based on vital capacity (VC) and forced expiratory volume in one second (FEV1.0).</p><p><strong>Results: </strong>Among 102 patients undergoing esophagectomy, 12 (11.8%) patients were included in the TTE group, and the remaining 90 (88.2%) patients were included in the TME group. Neoadjuvant treatments were significantly more common in the TTE group (p=0.011), with more advanced tumor stages (p=0.017). The TME group had significantly lower estimated blood loss (p=0.015). RF after esophagectomy showed a decrease in VC, and VC of predicted (%VC). The decrease rate in VC, %VC, and FEV1.0 was significantly greater in the TTE group than in the TME group.</p><p><strong>Conclusion: </strong>TME is a surgical procedure with a less severe postoperative decline in RF than TTE.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363778/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protective Effects of Imatinib on a DSS-induced Colitis Model Through Regulation of Apoptosis and Inflammation. 伊马替尼通过调节细胞凋亡和炎症对DSS诱导的结肠炎模型的保护作用
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13696
Hyeonjin Kim, Chae Yeon Kim, Dongwook Kim, Eungyung Kim, Lei Ma, Kanghyun Park, Zhibin Liu, K E Huang, Weihong Wen, Jiwon Ko, Su-Geun Lim, Younghun Sung, Zae Young Ryoo, Jun Koo Yi, Soyoung Jang, Myoung Ok Kim

Background/aim: Inflammatory bowel disease (IBD) is characterized by dysregulated immune responses and a multifactorial etiology. While imatinib has demonstrated efficacy in the treatment of immune-related diseases, its potential effects in IBD treatment remain underexplored.

Materials and methods: This study aimed to investigate the therapeutic effects of imatinib in colitis treatment. A dextran sulfate sodium (DSS)-induced colitis model was used to mimic IBD in mice. Imatinib was administered orally to mice simultaneously with DSS treatment. The effects of imatinib on DSS-induced colitis were evaluated by analyzing colitis-related pathology, including the disease activity index (DAI), histological lesions, inflammatory markers, and tight junction integrity. Additionally, western blot analysis and quantitative real-time polymerase chain reaction were used to assess inflammatory markers, tight-junction proteins, and cell death.

Results: In the DSS-induced colitis model, imatinib treatment exerted protective effects by attenuating weight loss, restoring colon length, reducing spleen weight, and improving the DAI score and histological lesions. Additionally, imatinib reduced the level of proinflammatory cytokines, including TNF-α, IL-6, and IL-1β. Furthermore, imatinib treatment restored tight-junction integrity and decreased the expression of apoptosis marker proteins.

Conclusion: Overall, imatinib treatment significantly alleviated the symptoms of DSS-induced colitis by influencing the expression of proinflammatory cytokines, tight junction proteins, and apoptotic markers in mice. These findings highlight imatinib as a potential therapeutic candidate for IBD.

背景/目的:炎症性肠病(IBD)的特点是免疫反应失调和多因素病因。虽然伊马替尼在治疗免疫相关疾病方面已显示出疗效,但其在IBD治疗中的潜在作用仍未得到充分探索:本研究旨在探讨伊马替尼在结肠炎治疗中的疗效。采用葡聚糖硫酸钠(DSS)诱导的结肠炎模型模拟小鼠的 IBD。小鼠在口服伊马替尼治疗右旋糖酐硫酸钠的同时口服伊马替尼。通过分析结肠炎相关病理,包括疾病活动指数(DAI)、组织学病变、炎症标志物和紧密连接完整性,评估了伊马替尼对DSS诱导的结肠炎的影响。此外,研究人员还使用了Western印迹分析和实时定量聚合酶链反应来评估炎症标志物、紧密连接蛋白和细胞死亡:结果:在DSS诱导的结肠炎模型中,伊马替尼通过减轻体重下降、恢复结肠长度、减轻脾脏重量、改善DAI评分和组织学病变发挥了保护作用。此外,伊马替尼还能降低促炎细胞因子的水平,包括 TNF-α、IL-6 和 IL-1β。此外,伊马替尼治疗还能恢复紧密连接的完整性,减少细胞凋亡标志蛋白的表达:总之,伊马替尼治疗通过影响小鼠促炎细胞因子、紧密连接蛋白和凋亡标志物的表达,明显缓解了DSS诱导的结肠炎症状。这些发现凸显了伊马替尼是一种潜在的 IBD 候选疗法。
{"title":"Protective Effects of Imatinib on a DSS-induced Colitis Model Through Regulation of Apoptosis and Inflammation.","authors":"Hyeonjin Kim, Chae Yeon Kim, Dongwook Kim, Eungyung Kim, Lei Ma, Kanghyun Park, Zhibin Liu, K E Huang, Weihong Wen, Jiwon Ko, Su-Geun Lim, Younghun Sung, Zae Young Ryoo, Jun Koo Yi, Soyoung Jang, Myoung Ok Kim","doi":"10.21873/invivo.13696","DOIUrl":"10.21873/invivo.13696","url":null,"abstract":"<p><strong>Background/aim: </strong>Inflammatory bowel disease (IBD) is characterized by dysregulated immune responses and a multifactorial etiology. While imatinib has demonstrated efficacy in the treatment of immune-related diseases, its potential effects in IBD treatment remain underexplored.</p><p><strong>Materials and methods: </strong>This study aimed to investigate the therapeutic effects of imatinib in colitis treatment. A dextran sulfate sodium (DSS)-induced colitis model was used to mimic IBD in mice. Imatinib was administered orally to mice simultaneously with DSS treatment. The effects of imatinib on DSS-induced colitis were evaluated by analyzing colitis-related pathology, including the disease activity index (DAI), histological lesions, inflammatory markers, and tight junction integrity. Additionally, western blot analysis and quantitative real-time polymerase chain reaction were used to assess inflammatory markers, tight-junction proteins, and cell death.</p><p><strong>Results: </strong>In the DSS-induced colitis model, imatinib treatment exerted protective effects by attenuating weight loss, restoring colon length, reducing spleen weight, and improving the DAI score and histological lesions. Additionally, imatinib reduced the level of proinflammatory cytokines, including TNF-α, IL-6, and IL-1β. Furthermore, imatinib treatment restored tight-junction integrity and decreased the expression of apoptosis marker proteins.</p><p><strong>Conclusion: </strong>Overall, imatinib treatment significantly alleviated the symptoms of DSS-induced colitis by influencing the expression of proinflammatory cytokines, tight junction proteins, and apoptotic markers in mice. These findings highlight imatinib as a potential therapeutic candidate for IBD.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363774/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EL4 Murine-Lymphoma-Stromal-Cell Fusion Hybrids Observed With Multiple Distinct Morphologies in the Primary Tumor and Metastatic Organs of a Syngeneic Mouse Model. 在共生小鼠模型的原发肿瘤和转移器官中观察到具有多种不同形态的 EL4 小鼠淋巴瘤-基质细胞融合杂交体。
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13673
Koji Yamashita, Atsushi Suetsugu, Sadanari Hayashi, Masahito Shimizu, Robert M Hoffman

Background/aim: We and others have previously shown that cell fusion plays an important role in cancer metastasis. Color coding of cancer and stromal cells with spectrally-distinct fluorescent proteins is a powerful tool, as pioneered by our laboratory to detect cell fusion. We have previously reported color-coded cell fusion between cancer cells and stromal cells in metastatic sites by using color-coded EL4 murine lymphoma cells and host mice expressing spectrally-distinct fluorescent proteins. Cell fusion occurred between cancer cells or, between cancer cells and normal cells, such as macrophages, fibroblasts, and mesenchymal stem cells. In the present study, the aim was to morphologically classify the fusion-hybrid cells observed in the primary tumor and multiple metastases EL4 formed from cells expressing red fluorescent protein (RFP) in transgenic mice expressing green fluorescent protein (GFP), in a syngeneic model.

Materials and methods: RFP-expressing EL4 murine lymphoma cells were cultured in vitro. EL4-RFP cells were harvested and injected intraperitoneally into immunocompetent transgenic C57/BL6-GFP mice to establish a syngeneic model. Two weeks later, mice were sacrificed and each organ was harvested, cultured, and observed using confocal microscopy.

Results: EL4 intraperitoneal tumors (primary) and metastases in the lung, liver, blood, and bone marrow were formed. All tumors were harvested and cultured. In all specimens, RFP-EL4 cells, GFP-stromal cells, and fused yellow-fluorescent hybrid cells were observed. The fused hybrid cells showed various morphologies. Immune cell-like round-shaped yellow-fluorescent fused cells had a tendency to decrease with time in liver metastases and circulating blood. In contrast fibroblast-like spindle-shaped yellow-fluorescent fused cells increased in the intraperitoneal primary tumor, lung metastases, and bone marrow.

Conclusion: Cell fusion between EL4-RFP cells and GFP stromal cells occurred in primary tumors and all metastatic sites. The morphology of the fused hybrid cells varied in the primary and metastatic sites. The present results suggest that fused cancer and stromal hybrid cells of varying morphology may play an important role in cancer progression.

背景/目的:我们和其他研究人员先前已经证明,细胞融合在癌症转移中起着重要作用。用光谱不同的荧光蛋白对癌细胞和基质细胞进行颜色编码是一种强大的工具,我们实验室率先使用这种工具来检测细胞融合。此前,我们曾利用彩色编码的 EL4 小鼠淋巴瘤细胞和表达光谱差异荧光蛋白的宿主小鼠,报道了转移部位癌细胞和基质细胞之间的彩色编码细胞融合。细胞融合发生在癌细胞之间或癌细胞与正常细胞(如巨噬细胞、成纤维细胞和间充质干细胞)之间。本研究的目的是对原发肿瘤和多发性转移瘤 EL4 中观察到的融合杂交细胞进行形态学分类,这些融合杂交细胞是由表达红色荧光蛋白(RFP)的细胞在表达绿色荧光蛋白(GFP)的转基因小鼠体内形成的:体外培养表达 RFP 的 EL4 小鼠淋巴瘤细胞。收获 EL4-RFP 细胞并将其腹腔注射到免疫功能正常的转基因 C57/BL6-GFP 小鼠体内,建立同种异体模型。两周后,小鼠被处死,每个器官被收获、培养,并使用共聚焦显微镜进行观察:结果:形成了 EL4 腹膜内肿瘤(原发性)以及肺、肝、血液和骨髓转移瘤。对所有肿瘤进行收获和培养。在所有标本中都观察到了 RFP-EL4 细胞、GFP-基质细胞和融合的黄色荧光混合细胞。融合的杂交细胞形态各异。在肝转移灶和循环血液中,免疫细胞类圆形黄色荧光融合细胞有随时间推移而减少的趋势。相反,成纤维细胞样纺锤形黄色荧光融合细胞在腹腔内原发肿瘤、肺转移灶和骨髓中增多:结论:EL4-RFP细胞与GFP基质细胞的融合发生在原发性肿瘤和所有转移部位。融合杂交细胞的形态在原发和转移部位有所不同。本研究结果表明,形态各异的融合癌细胞和基质杂交细胞可能在癌症进展过程中发挥重要作用。
{"title":"EL4 Murine-Lymphoma-Stromal-Cell Fusion Hybrids Observed With Multiple Distinct Morphologies in the Primary Tumor and Metastatic Organs of a Syngeneic Mouse Model.","authors":"Koji Yamashita, Atsushi Suetsugu, Sadanari Hayashi, Masahito Shimizu, Robert M Hoffman","doi":"10.21873/invivo.13673","DOIUrl":"10.21873/invivo.13673","url":null,"abstract":"<p><strong>Background/aim: </strong>We and others have previously shown that cell fusion plays an important role in cancer metastasis. Color coding of cancer and stromal cells with spectrally-distinct fluorescent proteins is a powerful tool, as pioneered by our laboratory to detect cell fusion. We have previously reported color-coded cell fusion between cancer cells and stromal cells in metastatic sites by using color-coded EL4 murine lymphoma cells and host mice expressing spectrally-distinct fluorescent proteins. Cell fusion occurred between cancer cells or, between cancer cells and normal cells, such as macrophages, fibroblasts, and mesenchymal stem cells. In the present study, the aim was to morphologically classify the fusion-hybrid cells observed in the primary tumor and multiple metastases EL4 formed from cells expressing red fluorescent protein (RFP) in transgenic mice expressing green fluorescent protein (GFP), in a syngeneic model.</p><p><strong>Materials and methods: </strong>RFP-expressing EL4 murine lymphoma cells were cultured in vitro. EL4-RFP cells were harvested and injected intraperitoneally into immunocompetent transgenic C57/BL6-GFP mice to establish a syngeneic model. Two weeks later, mice were sacrificed and each organ was harvested, cultured, and observed using confocal microscopy.</p><p><strong>Results: </strong>EL4 intraperitoneal tumors (primary) and metastases in the lung, liver, blood, and bone marrow were formed. All tumors were harvested and cultured. In all specimens, RFP-EL4 cells, GFP-stromal cells, and fused yellow-fluorescent hybrid cells were observed. The fused hybrid cells showed various morphologies. Immune cell-like round-shaped yellow-fluorescent fused cells had a tendency to decrease with time in liver metastases and circulating blood. In contrast fibroblast-like spindle-shaped yellow-fluorescent fused cells increased in the intraperitoneal primary tumor, lung metastases, and bone marrow.</p><p><strong>Conclusion: </strong>Cell fusion between EL4-RFP cells and GFP stromal cells occurred in primary tumors and all metastatic sites. The morphology of the fused hybrid cells varied in the primary and metastatic sites. The present results suggest that fused cancer and stromal hybrid cells of varying morphology may play an important role in cancer progression.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363744/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Large Complex Odontoma in the Angulus Mandibulae - Intraoral Enucleation as an Alternative to Mandibular Continuity Resection. 下颌角大型复杂性齿状瘤--口内去核术替代下颌连续性切除术。
IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-09-01 DOI: 10.21873/invivo.13726
Florian Dudde, Filip Barbarewicz, Wilken Bergmann, Adrian Zu Knyphausen, Kai-Olaf Henkel

Background: Odontomas are among the most common odontogenic tumors and are generally considered as hamartomatous odontogenic lesions. These tumors can be histopathologically divided into complex odontomas and compound odontomas based on their composition. Odontomas show a slow growing behavior and typically lack characteristic symptoms. The standard surgical treatment for large odontogenic tumors is a mandibular (continuity) resection followed by primary or secondary plastic reconstruction.

Case report: A 22-year-old male presented to the Department of maxillofacial surgery with an increasing feeling of pressure in the left mandible. An orthopantomogram revealed a large complex odontoma rg 038. Instead of mandible continuity resection an alternative minimally invasive technique/approach (intraoral) with a trapezoidal bone flap for the enucleation of an odontoma of the mandibular angle with subsequent flap reimplantation and osteosynthesis was performed.

Conclusion: Surgical enucleation of large mandibular odontoma with a continuity resection through an extraoral approach represents the surgical standard treatment of this entity. The present case report describes an alternative minimally invasive technique/approach. This technique may reduce surgical risks of the continuity resection through an extraoral approach (nerve damage, scarring) and can improve the long-term stability of the mandible by bone preservation.

背景:牙瘤是最常见的牙源性肿瘤之一,一般被认为是hamartomatous牙源性病变。这些肿瘤可根据其成分从组织病理学上分为复杂性牙瘤和复合性牙瘤。牙瘤生长缓慢,通常没有特征性症状。大型牙源性肿瘤的标准手术治疗方法是下颌骨(连续性)切除,然后进行一次或二次整形重建:病例报告:一名 22 岁的男性因左下颌骨压迫感加重而到颌面外科就诊。病例报告:一名 22 岁的男性因左侧下颌骨压迫感加重来到颌面外科就诊,正位畸形检查发现了一个巨大的复杂牙瘤 rg 038。手术采用了另一种微创技术/方法(口内),即使用梯形骨瓣对下颌角的牙瘤进行去核,随后进行骨瓣再植和骨合成,而不是进行下颌骨连续性切除:结论:通过口外方法对巨大下颌角牙瘤进行手术去核并进行连续性切除,是治疗这种牙瘤的外科标准方法。本病例报告介绍了另一种微创技术/方法。该技术可降低通过口外方法进行连续性切除的手术风险(神经损伤、疤痕),并可通过保留骨质提高下颌骨的长期稳定性。
{"title":"Large Complex Odontoma in the Angulus Mandibulae - Intraoral Enucleation as an Alternative to Mandibular Continuity Resection.","authors":"Florian Dudde, Filip Barbarewicz, Wilken Bergmann, Adrian Zu Knyphausen, Kai-Olaf Henkel","doi":"10.21873/invivo.13726","DOIUrl":"10.21873/invivo.13726","url":null,"abstract":"<p><strong>Background: </strong>Odontomas are among the most common odontogenic tumors and are generally considered as hamartomatous odontogenic lesions. These tumors can be histopathologically divided into complex odontomas and compound odontomas based on their composition. Odontomas show a slow growing behavior and typically lack characteristic symptoms. The standard surgical treatment for large odontogenic tumors is a mandibular (continuity) resection followed by primary or secondary plastic reconstruction.</p><p><strong>Case report: </strong>A 22-year-old male presented to the Department of maxillofacial surgery with an increasing feeling of pressure in the left mandible. An orthopantomogram revealed a large complex odontoma rg 038. Instead of mandible continuity resection an alternative minimally invasive technique/approach (intraoral) with a trapezoidal bone flap for the enucleation of an odontoma of the mandibular angle with subsequent flap reimplantation and osteosynthesis was performed.</p><p><strong>Conclusion: </strong>Surgical enucleation of large mandibular odontoma with a continuity resection through an extraoral approach represents the surgical standard treatment of this entity. The present case report describes an alternative minimally invasive technique/approach. This technique may reduce surgical risks of the continuity resection through an extraoral approach (nerve damage, scarring) and can improve the long-term stability of the mandible by bone preservation.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
In vivo
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1